European Commission grants marketing approval to Biogen's ALS drug

Quote
cafead

cafead

Administrator
Staff member
  • cafead   May 30, 2024 at 11:22: PM
via Biogen (BIIB.O), opens new tab said on Thursday that the European Commission has granted marketing authorization under exceptional circumstances for its amyotrophic lateral sclerosis (ALS) drug Qalsody.

article source
 

<



Similar threads

cafead
European Commission approves Astellas’ drug for expanded prostate cancer Treatment
Replies
0
Views
46
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
ViiV Healthcare receives European Commission approval for Apretude
Replies
0
Views
59
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Janssen granted additional European Commission approval for bispecific antibody
Replies
0
Views
85
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
First Gene Therapy for Hemophilia B, CSL&#039;s HEMGENIX®, Approved by the European Commission
Replies
0
Views
122
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
European Commission backs use of Moderna vaccine for children ages 12 and over
Replies
0
Views
75
Pharma/Biotech Companies - In the News
cafead
cafead
Top Bottom
Back
Quote